01.26.27 Injection Drug Use, Skin Ulcers, and Bacterial Infections: Improving Health Outcomes through Patient-Centered Care
Activity Announcement
Injection Drug Use, Skin Ulcers, and Bacterial Infections:
Improving Health Outcomes through Patient-Centered Care
Tuesday, January 26, 2027
12:00 pm – 1:00 pm
FREE, live Zoom Webinar
Hosted by Maryland Addiction Consultation Service (MACS)
Schedule:
|
Time
|
Content
|
|
12:00pm – 12:05pm
|
Introduction and overview of credit process
|
|
12:05pm – 12:20pm
|
Learning Objective #1:
Appreciate the connections between injection drug use, healthcare and social structures, and infections.
|
|
12:20pm – 12:35pm
|
Learning Objective #2:
Identify the roles of harm reduction and multidisciplinary care for people who use drugs.
|
|
12:35pm –12:50 pm
|
Learning Objective #3:
Understand the impact, treatment, and treatment challenges of injection-related skin ulcers.
|
|
12:50 pm–1:00 pm
|
Participant and Presenter Q&A
|
| |
|
Speaker:
Edward Traver, MD
Dr. Edward Traver is Assistant Professor of Medicine at the University of Maryland (UM) School of Medicine, jointly appointed in the Department of Medicine, Division of Infectious Disease and the Institute of Human Virology. A board-certified infectious disease physician, Dr. Traver is an expert in the care of bacterial infections and complex skin problems associated with injection drug use. Dr. Traver has been drawn to improving outcomes for people who inject drugs since his internal medicine residency in Baltimore, which has been disproportionately affected by the opioid epidemic.
At the IHV, Dr. Traver joined the Research Initiative for Infectious Disease and Substance Use (RIIS). He led the CHOICE+ retrospective cohort study of people hospitalized with injection-related infections and was integral in the design of the NIH HEAL Initiative-funded CHOICE-STAR trial, an innovative randomized, controlled trial evaluating an integrated infectious disease and addition clinic for people hospitalized with infections from injection drug use. Dr. Traver currently directs the Substance Use Disorder Study (SUDS), a natural history study of people with recent opioid, cocaine, or methamphetamine use.
Dr. Traver is a clinical and scientific expert on injection-related skin ulcers (IRSU). Within the CHOICE+, CHOICE-STAR, and SUDS studies, he has collected novel data on skin ulcer prevalence, risk factors, health outcomes, and association with xylazine, as well as methods to detect and avoid xylazine. Dr. Traver cares for people with infectious complications of injection drug use (including IRSU) at the UM multidisciplinary clinic for people with substance use disorders and is recognized as a valuable clinical resource, lecturing to medical students, medical residents, and infectious disease fellows.
Target Audience: Medical Doctors, Advanced Practice Registered Nurses, Nurse Practitioners, Physician Assistants, Behavioral Health Professionals, Pharmacists, and other members of the healthcare team.
CME Credit: 1 Contact Hour pending
CEU Credit: 1.0 Contact Hour pending
Learning Objectives:
By the end of the session, participants will be able to:
- Appreciate the connections between injection drug use, healthcare and social structures, and infections.
- Identify the roles of harm reduction and multidisciplinary care for people who use drugs.
- Understand the impact, treatment, and treatment challenges of injection-related skin ulcers.
